TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,662,900
|
2,727,943
|
2,501,945 |
Financial expenses |
16,608
|
11,016
|
11,167 |
Earnings before taxes |
206,127
|
167,702
|
174,721 |
EBITDA |
217,674
|
179,848
|
187,333 |
Total assets |
827,708
|
902,489
|
821,604 |
Current assets |
810,852
|
884,714
|
803,737 |
Current liabilities |
243,654
|
324,567
|
368,388 |
Equity capital |
504,054
|
443,322
|
318,616 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
24
|
21
![]() |
21 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
60.9%
|
49.1%
|
38.8% |
Turnover per employee |
110,954
|
129,902
|
119,140 |
Profit as a percentage of turnover |
7.7%
|
6.1%
|
7.0% |
Return on assets (ROA) |
26.9%
|
19.8%
|
22.6% |
Current ratio |
332.8%
|
272.6%
|
218.2% |
Return on equity (ROE) |
40.9%
|
37.8%
|
54.8% |
Change turnover |
-65,043
|
225,998
|
591,715 |
Change turnover % |
-2%
|
9%
|
31% |
Chg. No. of employees |
3
|
0
|
1 |
Chg. No. of employees % |
14%
|
0%
|
5% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.